Home›Stock Screener›Astec Lifesciences

Astec Lifesciences Share Price Today | Stock Price & Astec Lifesciences Share Screener

ASTEC Fertilizers & Agrochemicals
Live Share Price NSE
₹552.45
▲ 4.10 (0.75%)
2026-11-19 00:00:00
Live Share Price BSE
₹554.10
▲ 5.05 (0.92%)
2026-11-19 00:00:00

As of November 19, 2026, the live Astec Lifesciences share price (NSE: ASTEC) is ₹552.45 on NSE and ₹554.10 on BSE, up 0.75% from the previous close, with shares trading between ₹541.55 and ₹557.95 in today's trading session, and a 52-week range of ₹521.85–₹918.75. Track ASTEC market cap trends to gauge the company's total market size. Use the Astec Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Astec Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹161 and net income of ₹-8, with EBITDA of ₹12, an operating margin of 6.0% and a profit margin of -5.0%.

Astec Lifesciences Market Cap ₹1,233.13 Cr.
ASTEC P/E Ratio (TTM) -15.50
Astec Lifesciences P/B Ratio 3.68
EPS (TTM) ₹-37.79
Dividend Yield 0.27%
Debt to Equity 1.60
ASTEC 52 Week High ₹918.75
Astec Lifesciences 52 Week Low ₹521.85
Operating Margin 6.00%
Profit Margin -4.97%
ASTEC Revenue (TTM) ₹161.00
EBITDA ₹12.00
Net Income ₹-8.00
Total Assets ₹942.00
Total Equity ₹391.00

Astec Lifesciences Share Price Chart

Track the current stock price of Astec Lifesciences with an interactive chart. Analyse ASTEC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Astec Lifesciences stock quote in one place.

The quote of ₹552.45 sits between the 52-week low of ₹521.85 and the 52-week high of ₹918.75, and the latest session moved 0.75% from the previous close.

Astec Lifesciences Company Profile - Fundamental Screener

Screen Astec Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTEC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Fertilizers & Agrochemicals industry, and it trades under ISIN INE563J01010.

Company Details

Classification

Sector Chemicals
Industry Fertilizers & Agrochemicals
Sub-Sector Fertilizers & Agrochemicals
Segment E

Identifiers and Leadership

ISIN INE563J01010

Astec Lifesciences Balance Sheet Screener

Screen ASTEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹942, up from ₹881 in 2025.

Latest statistics put total assets at ₹942 and shareholder funds at ₹391, with a leverage ratio of 1.60.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 942 881 975 979 897 678 572 461 413 334
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 459 499 386 319 340 213 194 167 115 103

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 51 281 208 34 10 46 7 10 5 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 391 235 370 420 397 309 247 203 170 138
Share Capital 22 20 20 20 20 20 20 20 20 20
Reserves & Surplus 368 215 350 400 377 290 227 183 150 119

Astec Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen Astec Lifesciences income statement and profit fundamentals. Analyze ASTEC quarterly results. Astec Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹161 and net profit was ₹-8, equal to earnings per unit of ₹-3.48, at an operating margin of 6%.

In that period expenses were ₹150, interest cost ₹8 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹84 and net profit of ₹-19.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 161 84 73 120 92 75 126 156 70 101 96 130 145 112 52
Expenses 150 84 92 114 102 80 123 141 116 118 100 122 140 114 69

Operating Costs and Margins

EBITDA 12 0 -19 6 -11 -6 3 15 -45 -18 -4 8 5 -2 -17
Operating Profit % 6.00% -1.00% -27.00% 5.00% -12.00% -9.00% 2.00% 8.00% -67.00% -20.00% -6.00% 4.00% 2.00% -3.00% -36.00%
Depreciation 12 11 11 12 12 10 11 9 9 12 11 8 9 9 9
Interest 8 8 7 10 11 8 7 7 7 9 10 6 7 6 6

Profit and Earnings

Profit Before Tax -8 -19 -37 -16 -33 -24 -16 -1 -62 -39 -25 -6 -11 -18 -32
Tax 0 0 0 0 0 0 0 0 -22 0 15 -1 -3 -4 -8
Net Profit -8 -19 -37 -16 -33 -24 -16 -1 -40 -39 -40 -5 -8 -13 -24
EPS -3.48 -8.40 -16.79 -8.20 -16.85 -11.35 -7.04 -0.50 -20.26 -19.66 -20.59 -2.54 -4.18 -6.85 -12.41

Astec Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen ASTEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹81, and net cash flow was an inflow of ₹10.

Over the same period, investing activities used ₹4 and financing activities provided ₹95.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -81 -8 10 75 24 -8 168 15 65 19
Investing Activities -4 -15 -135 -113 -104 -73 -74 -53 -49 -18

Financing and Net Cash

Financing Activities 95 24 125 38 81 81 -95 37 -18 -1
Net Cash Flow 10 0 0 0 0 0 0 0 -3 1

Astec Lifesciences Shareholding Pattern Screener

See Astec Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Astec Lifesciences promoter holding and ownership changes for ASTEC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 71.97%, foreign institutions 0.02%, domestic institutions 3.34% and the public 20.81%, spread across 21,041 shareholders.

The shareholder count was 21,041 in 2026-Mar, compared with 19,889 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Jul 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 71.97% 71.96% 71.96% 70.87% 70.87% 72.42% 72.42% 71.97%

Institutional Investors

FII Holding 0.02% 0.01% 0.03% 0.25% 0.02% 0.02% 0.00% 0.04%
DII Holding 3.34% 3.33% 3.34% 4.34% 4.26% 4.01% 4.01% 3.17%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.81% 20.48% 20.04% 19.62% 19.98% 18.96% 19.32% 20.87%
Other Holding 3.86% 4.22% 4.63% 4.91% 4.87% 4.59% 4.25% 3.95%
Shareholder Count 21,041 19,889 19,707 18,689 18,549 18,889 18,276 22,293

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Astec Lifesciences. Astec Lifesciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹1.50 0.14%
2022-March ₹1.50 0.11%
2021-March ₹1.50 0.09%
2020-March ₹1.50 0.15%
2019-March ₹1.50 0.39%
2018-March ₹1.50 0.28%
2017-March ₹1.50 0.26%

Astec Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include Astec Lifesciences stock. Check ASTEC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP

Astec Lifesciences Market Events Screener - Corporate Actions

Get Astec Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Astec Lifesciences stock events that may affect ASTEC share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 26, 2026, with a record date of October 26, 2026.

It is followed by Quarterly Result Announcement dated July 31, 2026 and Annual General Meeting dated July 31, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-26 2026-10-26 Quarterly Result Announcement NA -8.56%
2026-07-31 2026-07-31 Quarterly Result Announcement NA -8.33%
2026-07-31 2026-07-31 Annual General Meeting NA -13.10%
2026-04-27 2026-04-27 Quarterly Result Announcement NA -3.59%
2026-01-30 2026-01-30 Quarterly Result Announcement NA -12.93%
2025-10-29 2025-10-29 Quarterly Result Announcement NA -8.59%
2025-07-28 2025-07-28 Quarterly Result Announcement NA 0.28%
2025-07-28 2025-07-28 Annual General Meeting NA 18.90%
2025-07-04 2025-07-04 Rights 1:7 1.17%
2025-04-23 2025-04-23 Quarterly Result Announcement NA 8.19%
2025-01-27 2025-01-27 Quarterly Result Announcement NA -5.28%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -2.20%
2024-07-29 2024-07-29 Annual General Meeting NA -0.11%
2023-07-27 2023-07-27 Annual General Meeting NA -6.19%
2023-07-21 2023-07-22 Dividend ₹ 1.50 /share -2.96%

Astec Lifesciences Competitors Screener - Peer Stocks Comparison

Screen ASTEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Coromandel International 58,083 38.70 31,827 30.21% 1,898 63.22
Fertilisers & Chemical Travancore 51,374 -494.10 4,267 -18.78% 41 61.49
UPL 47,565 21.60 52,502 11.41% 2,220 62.95
PI Industries 25,489 29.60 7,024 -15.59% 1,321 26.66
Sumitomo Chemical 17,206 31.00 3,385 3.56% 543 39.59
Bayer Crop Science 15,243 20.80 5,770 3.16% 689 45.55
Chambal Fertilisers & Chemicals 14,884 8.10 20,921 24.07% 1,953 41.78
Paradeep Phosphates 14,209 17.10 21,973 28.45% 996 43.19
EID Parry 11,534 12.40 38,883 21.63% 1,381 46.19
Madhya Bharat Agro 8,915 58.10 1,884 75.99% 150 66.28

Astec Lifesciences Company Announcements - News & Reports Screener

Screen ASTEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 16, 2026.

The next most recent announcements are dated November 15, 2026 and October 27, 2026.

Date Update Actions
2026-11-16 Reply To Volume Movement Letter -
2026-11-15 Clarification sought from Astec Lifesciences Ltd -
2026-10-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-26 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-26 Financials Results -
2026-10-26 Board Meeting Outcome for Outcome Of Board Meeting -
2026-10-16 Board Meeting Intimation for Meeting Scheduled On October 26 2026 -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Response To Volume Movement Letter -
2026-10-01 Clarification sought from Astec Lifesciences Ltd -
2026-09-28 Closure of Trading Window -
2026-09-18 Response To BSE Query Dated 18.09.2026 -
2026-09-18 Clarification sought from Astec Lifesciences Ltd -
2026-09-11 Response To BSE E-Mail Seeking Clarification On Price Movement -
2026-09-10 Clarification sought from Astec Lifesciences Ltd -
2026-09-09 Reply To BSE Query Regarding Volume Movement Dated September 9 2026 -
2026-09-09 Clarification sought from Astec Lifesciences Ltd -
2026-08-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-31 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-31 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹552.45, within a 52-week range of ₹521.85 to ₹918.75. The P/E ratio is -15.50 and the P/B ratio is 3.68, with earnings per unit of ₹-37.79. Market capitalisation stands at ₹1,233.13 Cr and the dividend yield is 0.27%. The company operates in the Chemicals sector, in the Fertilizers & Agrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.